High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells

Jennifer S Chen,Ryan D Chow,Eric Song,Tianyang Mao,Benjamin Israelow,Kathy Kamath,Joel Bozekowski,Winston A Haynes,Renata B Filler,Bridget L Menasche,Jin Wei,Mia Madel Alfajaro,Wenzhi Song,Lei Peng,Lauren Carter,Jason S Weinstein,Uthaman Gowthaman,Sidi Chen,Joe Craft,John C Shon,Akiko Iwasaki,Craig B Wilen,Stephanie C Eisenbarth,Jennifer S. Chen,Ryan D. Chow,Winston A. Haynes,Renata B. Filler,Bridget L. Menasche,Jason S. Weinstein,John C. Shon,Craig B. Wilen,Stephanie C. Eisenbarth

DOI: https://doi.org/10.1126/sciimmunol.abl5652

IF: 30.63

2022-02-04

Science Immunology

Abstract:T follicular helper (T FH ) cells are the conventional drivers of protective, germinal center (GC)–based antiviral antibody responses. However, loss of T FH cells and GCs has been observed in patients with severe COVID-19. As T cell–B cell interactions and immunoglobulin class switching still occur in these patients, noncanonical pathways of antibody production may be operative during SARS-CoV-2 infection. We found that both T FH -dependent and -independent antibodies were induced against SARS-CoV-2 infection, SARS-CoV-2 vaccination, and influenza A virus infection. Although T FH -independent antibodies to SARS-CoV-2 had evidence of reduced somatic hypermutation, they were still high affinity, durable, and reactive against diverse spike-derived epitopes and were capable of neutralizing both homologous SARS-CoV-2 and the B.1.351 (beta) variant of concern. We found by epitope mapping and B cell receptor sequencing that T FH cells focused the B cell response, and therefore, in the absence of T FH cells, a more diverse clonal repertoire was maintained. These data support an alternative pathway for the induction of B cell responses during viral infection that enables effective, neutralizing antibody production to complement traditional GC-derived antibodies that might compensate for GCs damaged by viral inflammation.

immunology